|
Outcomes of simultaneous, adaptive, MRI-guided liver SBRT in patients with heavily pretreated colorectal cancer and four or more liver metastases. |
| |
|
Employment - The Ohio State University Wexner Medical Center (I); University of Wisconsin Hospitals and Clinics |
| |
|
No Relationships to Disclose |
| |
|
Employment - University of Wisconsin Hospitals and Clinics |
| |
|
Employment - University of Wisconsin Hospitals and Clinics |
Research Funding - GE Healthcare |
Patents, Royalties, Other Intellectual Property - US10201324B2 Patient interface system, method, and apparatus for categorizing whole-breast density from acoustic signal |
Travel, Accommodations, Expenses - Varian Medical Systems |
| |
|
Employment - University of Wisconsin Hospitals and Clinics |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - OncLive/MJH Life Sciences |
| |
|
Employment - University of Wisconsin Hospitals and Clinics |
Stock and Other Ownership Interests - Elephas Bio |
Consulting or Advisory Role - Elephas Bio |
Research Funding - Agios (Inst); AstraZeneca/MedImmune/Spirogen (Inst); Bristol Myers Squibb Foundation (Inst); Incyte (Inst) |
| |
|
Consulting or Advisory Role - Abbvie; Abbvie; Personal Genome Diagnostics |
Research Funding - Exact Sciences |
| |
|
Stock and Other Ownership Interests - Exact Sciences (I); Natera (I) |
Consulting or Advisory Role - Arcus Biosciences; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; BeiGene; Bristol Myers Squibb Foundation; Bristol-Myers Squibb/Roche; Eisai; Eisai/MSD; Elevation Oncology; GRAIL; Ipsen; ipsen; Lilly; Merck; Strata Oncology |
Research Funding - Arcus Biosciences (Inst); EMD Serono (Inst); ipsen (Inst) |
| |
|
|
Consulting or Advisory Role - Boehringer Ingelheim; Cardinal Health; I-Mab |
Research Funding - BMS; Boehringer Ingelheim; Mirati Therapeutics |
Patents, Royalties, Other Intellectual Property - WARF (patent filling) co-developed with StemPharm |
Travel, Accommodations, Expenses - Total Health Conferencing; TriSalus Life Sciences |
| |
|
Consulting or Advisory Role - Foundation Medicine; Illumina; Pfizer; Regeneron; Seagen; Taiho Oncology |
Research Funding - AADi (Inst); Arcus Ventures (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Curegenix (Inst); Genentech (Inst); Ipsen; Lilly (Inst); Merck (Inst); Millennium (Inst); Natera (Inst); Promega (Inst); Revolution Medicines (Inst); Strata Oncology (Inst) |
| |
|
Employment - Madison VA Hospital; UW Health; UW Health (I) |
Stock and Other Ownership Interests - GE Healthcare; Pfizer |
Research Funding - GE Healthcare (I) |
Patents, Royalties, Other Intellectual Property - 1. Glide-Hurst, C., Duric, N., & Littrup, P. (2015). U.S. Patent No. 20,150,005,635. “Method and apparatus for categorizing breast density and assessing cancer risk utilizing acoustic parameters.” Washington, DC: U.S. Patent and Trademark Office 2. Glide- (I) |
Other Relationship - Medscint (I); Modus QA Medical Devices (I) |
| |
|
No Relationships to Disclose |